UMIN ID: UMIN000002784
Registered date:01/12/2009
The effect of maxacalcitol on cardiovascular disesase in hemodialysis patients
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | Chronic kidney disease |
| Date of first enrollment | 2009/12/01 |
| Target sample size | 52 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Maxacalcitol therapy Conventional therpy (oral vitamin D treatment) |
Outcome(s)
| Primary Outcome | Left ventricular mass index |
|---|---|
| Secondary Outcome | Intimal plus medial complex thickness Coronary artery calcification score Pulse wave velocity Dual energy X-ray absorptiometry Bone metabolism marker Inflamatory marker Oxidative stress marker Parathyroid gland volume Correlation between bone and artery Correlation between vitamin D level and vascular calcification |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Post history of intravenous vitamin D therapy Post history of cicalcet HCl treatment Post history of peritoneal dialysis or kidney transplantion Pregnant woman Post history of severe cardiovascular disease |
Related Information
| Primary Sponsor | Department of Medicine and Clinical Science, Kyushu University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Chugai Pharmaceutical Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Masatomo Taniguchi |
| Address | Maidashi 3-1-1, Higashi-ku, Fukuoka, Japan Japan |
| Telephone | 092-642-5256 |
| masatomo@kcu.med.kyushu-u.ac.jp | |
| Affiliation | Kyushu University, Graduate School of Medical Sciences Department of Medicine and Clinical Science |
| scientific contact | |
| Name | Kazuhiko Tsuruya |
| Address | Maidashi 3-1-1, Higashi-ku, Fukuoka, Japan Japan |
| Telephone | 092-642-5843 |
| Affiliation | Kyushu University, Graduate School of Medical Sciences Department of Integrated Therapy for Chronic Kidney Disease |